O ver two decades have passed since abnormalities in plasma and myocardial catecholamines in patients with congestive heart failure were described.1 These observations now have been confirmed in a variety of models of myocardial hypertrophy and heart failure.2-4 However, the relations between myocardial f3-adrenergic receptor (,AR) number and physiological responsiveness in these models are variable, depending on the species studied, the stress used to produce myocardial hypertrophy and/or heart failure, and the time course of the perturbation. Thus Isoproterenol-Stimulated Chronotropic Response After recovery from thoracotomy (7-14 days), animals underwent pharmacological testing using (-)isoproterenol.12 These tests were repeated again after fistula placement when signs of circulatory congestion (tachycardia, tachypnea) had developed. Tests were conducted in early morning hours in a quiet, dark laboratory (21°C). Response to isoproterenol was assessed by graded bolus injections of (-)isoproterenol (10-500 gg/kg i.v.) while recording heart rate until there was no further increase (usually 30 seconds). The 12-second period showing the largest increase in heart rate was taken as the maximal response. This interval always included at least one full respiratory cycle. Heart rate returned to baseline between each dose of isoproterenol. Injections were given until there was <5% increase in heart rate; the preceding dose was chosen as the one that caused a maximal response. The relation between change in heart rate and the logarithm of the dose of (-)isoproterenol (gg/kg) was examined by linear regression analysis. Two or three tests conducted on separate days were combined into a single linear regression in each animal. The dose of isoproterenol yielding ED5, was calculated from the linear regres-sion equation. Two animals were studied after intravenous administration of hexamethonium bromide (100 mg/kg), atropine sulfate (0.075 mg/kg), and prazosin (0.1 mg/kg) to eliminate variations in reflex autonomic tone and peripheral vasoconstriction known to accompany the congested circulatory state.
Terminal Surgery
Forty-eight to 72 hours after completion of all pharmacological and physiological testing, animals were anesthetized and intubated and midline sternotomies were made. The heart was removed and placed in iced saline (4°C), and the RA, left atrium, and right ventricular free wall were removed. The right ventricle (RV), LV, and septum were weighed. RA samples were obtained from identical regions in all animals. Transmural samples of LV free wall were taken midway from base to apex near the midportion of the left anterior descending coronary artery. Myocardial samples were rinsed free of blood and frozen (-70°C). Time from heart removal to placing samples in liquid nitrogen was 10-15 minutes.
Membrane Preparation
Frozen (-70°C) transmural samples were powdered in a stainless steel mortar and pestle (also -70°C), placed in Tris buffer, glass-glass homogenized, and contractile proteins were extracted (0.5 mol/l KCI, 20 minutes, 4°C Experiments were conducted to establish that }3-receptors were not lost to the supernatant. When LV membranes were prepared (as above), K+-pNPPase activity, a marker for sarcolemmal membrane, was negligible in the supernatant. We therefore concluded that receptors, if present in the supernatant, must be unassociated with sarcolemmal membrane fragments. To detect solubilized receptors, we dialyzed 10 ml of supernatant from a 45,000g centrifugation with 1.0 1 of potassium-deficient Tris buffer overnight at 4°C to reduce KCl concentration, to prevent interference with the receptor-radioligand interaction. Supernatants (0.3 mg/ml) then were used in saturation isotherm experiments (n=2; LV from control and volume-overloaded animals). GF/C filter paper was pretreated with 2% polyethylenimine to trap solubilized receptors. 16 There was no specifically bound ICYP in the supernatant fraction of control or volume-overloaded animals. Thus, we believe that data obtained from saturation isotherms conducted on the membrane preparation used accounts for all of the /3-receptors.
Adenylyl Cyclase Assays
Methods were modified from Salomon.17 Adenylate cyclase activity was determined in a final volume of 100 gl and the assay mixture included final con- ,u mol/l; isoproterenol, 10 ,umol/l; and NaF, 10 mmol/l. Reactions were initiated by adding 120-140 ,ug of myocardial membrane homogenate to ice-cold reactants, then incubating at 37°C for 15 minutes. We found that cAMP production under these conditions was linear with respect to time and protein concentration, and that 3-isobutyl, 2-methylxanthine (1.0 mmol/l), adenosine deaminase (5 U/ml), or both, had no effect on basal or maximally stimulated cAMP production. Reactions were terminated by placing tubes in an ice-cold bath and adding 100 ,ul of stopping solution containing 40 mmol/l ATP, 1.4 mmol/l cAMP, ['H]-cAMP (7,000 cpm), 50 mmol/l Tris-HCl (pH 7.5), and sodium dodecyl S04 (2%) to each tube, and heated to 100°C for 3 minutes.
Volumes then were brought to 1 ml by adding 800 jil of water, and cAMP was fractionated using Dowexalumina sequential column chromatography.17 Recovery was 75-92% using these methods with replicate variation less than 10%.
Experiments were conducted to establish that adenylyl cyclase activity is not lost in the supernatant of a 45,0QOg centrifugation. We found that forskolin-stimulated cAMP production was very low in the supernatant of a 45,000g centrifugation prepared from LV membranes (supernatant, 18 pmol/mg/min; pellet, 541 pmol/mg/min; n=2). Thus, a negligible amount of adenylyl cyclase activity is found in the supernatant fraction of routine membrane preparations.
Assessment of Gs
We modified a reconstitution assay for use with porcine myocardial membranes. ' inactivate Gs). Preactivation was initiated by adding 10 ,ul of 1.0 mmol/l GTP, 10 gl of 100 mmol/l NaF, and 16.5 ,ul of reaction buffer, and incubating for 20 minutes at 30°C. Adenylate cyclase activity was assayed by adding [a-'2P]-ATP (800,000 cpm) in 23.5 pul of water to each sample tube and incubating for 10 minutes at 30°C. The reaction then was terminated and cAMP production was measured as described above. Reconstitution assays were performed on undiluted extract and several serial dilutions, giving a wide range of protein content. We have found that intrinsic adenylyl cyclase activity in extract and cycmembranes is negligible, and that NaF stimulation of cyc membranes yields no cAMP production. In preliminary studies, we found cAMP production to be proportional to the amount of extract added (from potential confounding influence of variation in catalytic subunit concentration in cyc-membranes. Data are expressed as picomole of cAMP produced per 10 minutes as a function of membrane protein used for the detergent extraction.
Assessment of Gi
We used pertussis toxin-dependent ADP ribosylation to assess Gi in membrane homogenates from RA ,ug pertussis toxin (pH 8.0). Preactivation of pertussis toxin was not necessary to achieve maximal ribosylation if toxin was added simultaneously with 10 mmol/l DTT. Optimal incubation time and protein and NAD concentrations were determined in preliminary experiments.
Plasma and Tissue Catecholamine Measurements
Blood samples were obtained from animals in the basal state 2-3 weeks after thoracotomy (before aortocaval fistula) and again just before they were killed. Levels of epinephrine and norepinephrine in plasma and myocardium were determined using a previously described sensitive radioenzymatic assay2' and were expressed as catecholamine per milligram of wet tissue.
Histological Examination
LV samples were prepared for light microscopy and stained with hematoxylin and eosin for general histological assessment or with Masson's trichrome stain to assess degree of fibrosis.
Data Analysis
Data are expressed as mean+1 SD. Specific measurements are compared before and after the volume-overloaded state in each animal using Student's t test for paired data. The null hypothesis was rejected when probability was less than 0.05 (twotailed). The Pearson product-moment correlation coefficient (r) is reported as a measure of the strength of association between change in heart rate and logarithm of dose of isoproterenol determined by linear regression analysis. Saturation isotherm experiments underwent Scatchard analysis, and competition binding experiments were analyzed with the nonlinear regression program found in Graphpad (Harvey Motulsky, University of California San Diego). F ratios were used to test whether one-or two-component curves better fit the data, and when equivalent, the simpler model was selected.
Results
Characterization of the Model Table 1 shows that 4-5 weeks after creation of aortocaval fistula, animals had increased basal heart rate: Control (CON) was 93+± 10 beats per minute, volume overload (VOL) was 130+20 beats per Figure 1 shows that 4-5 weeks after creation of aortocaval fistula, animals had increased levels of both plasma epinephrine (CON, 36±30 pg/ml; VOL, 384 ±255 pg/ml; p<0.05) and norepinephrine (CON, 191±133 pg/ml; VOL. 1,054+443 pg/ml;p<0.01). In contrast, compared with the control state, myocardial levels of norepinephrine were reduced both in RA (CON, 5,165±1,834 pg/mg; VOL, 1,292+1,034 pg/ mg;p<0.01) and LV (CON, 2,549± 847 pg/mg; VOL, 514±351 pg/mg;p<0.001). Levels of myocardial epinephrine were unchanged by hypertrophy and circulatory congestion.
Isoproterenol-Stimulated Chronotropic Response Figure 2 shows results of dose-response studies examining the ability of graded bolus doses of (-)isoproterenol to increase heart rate. These studies were performed before and after development of circula- tory congestion in nine animals. Basal heart rate increased (Table 1) , but maximal isoproterenol-stimulated heart rate tended to decrease (CON, 230+ 17 beats per minute; VOL, 207±34 beats per minute; p=0.06) and maximal change in heart rate decreased (CON, 127±+16 beats per minute; VOL, 70+±38 beats per minute; p=0.002). As shown in Figure 2 , isoproterenol ED50 for heart rate change was increased 133% after circulatory congestion developed (CON, 0.06±0.03 gg/kg; VOL, 0.14+0.07 ,ug/kg;p=0.001).
In addition, the slope relating the dose of isoproterenol with heart rate change ( Figure 2) Table 2) . Table 3 and Figure 4 summarize data from competitive radioligand binding experiments using (-)isoproterenol. The Membranes from control (n =7) and volume-overloaded animals (n =7) were studied simultaneously, stimulated with ,3-receptor-dependent and GQ-dependent agents, and cyclic adenosine monophosphate (cAMP) production was measured. In all cases, myocardium from volume-overloaded animals showed marked diminution in cAMP production.
Data represent cAMP produced in pmol/min/mg protein+ 1 SD, and are net values (basal subtracted). p, control vs. volume overload, two-tailed t test; CON, control; VOL, volume overload; ISO, 10 ,umol/l isoproterenol, Gpp, 100 ,umol/l 5'-guanylyimidodiphosphate; NaF, 10 animals (control, 30% high affinity; volume overload, 0% high affinity), suggesting an uncoupling of /3-adrenergic receptors and Gs. See Table 3 for mean data from all animals. VOL, volume-overloaded animals; ICYP, '2SIlabeled cyanopindolol.
branes from RA and LV ( Figure 7) . We found that pertussis toxin-catalyzed incorporation of ["2P] into sarcolemmal membranes was similar in both RA (CON, 2,414±526 fmol/mg; VOL, 2,039±526 fmol/ mg;p=NS) and LV (CON, 1,570±390 fmol/mg; VOL, 1,470 369 fmollmg; p=NS). These data suggest that depressed cAMP production was not due to an enhanced inhibition of adenylate cyclase activity by Gi.
Specific Effects of Thoracotomy
We have shown previously that myocardial ,3AR number and heart rate responsiveness to isoprotere- nol stimulation are not affected by thoracotomy.12 In the present study, seven animals were used to determine whether adenylyl cyclase activity was altered by thoracotomy and instrumentation independently from effects of aortocaval fistula. Three pigs underwent thoracotomy and instrumentation and were killed 50±10 days later (THOR). These animals were compared in side-by-side assays with four additional control animals that were killed without prior thoracotomy or instrumentation (CON-THOR). Adenylyl cyclase activity in LV membrane homogenates from pigs that had undergone thoracotomy alone was not decreased; measurements were as follows: basal (CON-THOR, 87±8 pmol/min/mg; THOR, 87±12 pmol/min/mg); isoproterenol and Gpp[NHIp-stimulated (CON-THOR, 407±49 pmol/min/mg; THOR, 373 ± 208 pmol/min/mg); Gpp[NH]p-stimulated (CON-THOR, 344±18 pmol/min/mg; THOR, 315 ± 141 pmol/min/mg); NaF-stimulated (CON-THOR, 245±29 pmol/min/mg; THOR, 216±82 pmol/min/mg); forskolin-stimulated (CON-THOR, 853±167 pmol/min/mg; THOR, 718±113 pmol/min/ mg); Mn2+-stimulated (CON-THOR, 79±6 pmol/ min/mg; THOR, 73±8 pmol/min/mg). Therefore, differences in ,BAR expression and adenylyl cyclase activity in this study were not due to the effects of thoracotomy alone.
Histological Analyses
Histological analyses of myocardium from volumeoverloaded animals did not show inflammatory infiltrates or fibrosis.
Discussion
There are four principal findings of this work. First, chronic volume-overload-induced cardiac hypertrophy with circulatory congestion is associated with multichamber myocardial desensitization affecting many elements of the 63AR-dependent adenylate cyclase pathway from initial interaction of agonist with receptor to final physiological response in vivo. These data suggest a catecholamine-driven desensitization of cardiac ,B-adrenergic receptors, adenylyl cyclase, and cardiac Gs. Second, our data imply that abnormalities in myocardial ,BAR-dependent signal transduction can occur despite normal contractile function, in the absence of myocardial fibrosis, and without associated pharmacological therapy. These findings indicate that activation of the sympathetic nervous system with enhanced release of endogenous catecholamines is associated with prominent changes in myocardial signal transduction and that these changes do not require precedent abnormalities in myocyte function. Third, downregulation of myocardial ,BAR number by volume-overload hypertrophy is selective for the p1-receptor subtype and is similar in magnitude in membranes from RA, RV, and LV. These data imply that norepinephrine, released from myocardial adrenergic nerves and abundant in plasma from volume-overloaded animals, may be of greater importance mechanistically in downregula- caused by cardiomyopathy or coronary heart disease, entities associated with myocardial fibrosis. Reduced PAR number may have been due in part to fibrosis rather than to an actual decrease in ,AR number on cardiac myocytes. In addition, such patients take medications that interact with ,-receptors, so that changes in ,BAR expression may have been due in part to medical therapy. Animal models of myocardial hypertrophy and heart failure can complement clinical studies because they provide a means of circumventing some of these problems.
Several studies in animals have used aortic banding to study the effects of pressure-overload hypertrophy on PAR expression; these studies have yielded quite variable results. Karliner et a125 found increased myocardial BAR number in pressure-overload hypertrophy with associated heart failure in guinea pigs. Vatner et a126 also found upregulation of myocardial PAR number in dogs with pressure-overload hypertrophy from aortic banding. Later studies from their laboratory27 confirmed the finding of 8AR upregulation even when animals showed signs of circulatory congestion. Recently, this same group reported that diminution of adenylyl cyclase activity in myocardial membranes from dogs with pressure-overload hypertrophy may be due to decreased levels of Gs as assessed by cholera toxin labeling and by reconstitution studies using cells deficient in Gs. Although circulatory congestion resulting from volume-overload hypertrophy secondary to aortocaval fistula is fundamentally different from circulatory congestion seen in clinical dilated heart failure, there are striking similarities. For example, plasma catecholamines are elevated, and myocardial norepinephrine levels are decreased in both entities. In both circumstances, the symptoms and signs of circulatory congestion are dominant (tachypnea, ascites, tachycardia), and in both cases, cardiac dilation without striking concentric hypertrophy characterize the anatomic changes of the heart. There are important differences between the two models. First, plasma epinephrine levels are higher in the current model than in clinical dilated heart failure, a feature that may have contributed to changes in myocardial ,3AR expression. Second, dilated heart failure is usually irreversible; in contrast, in the aortocaval fistula model, after the fistula is closed, all signs of circulatory congestion disappear.6 Furthermore, despite circulatory congestion, papillary muscle taken from animals with circulatory congestion caused by aortocaval fistula show entirely normal or increased contraction characteristics in vitro. 6 In summary, despite normal cardiac muscle function in vitro, volume-overload-induced myocardial hypertrophy is associated with physiological and biochemical abnormalities that mimic clinical dilated heart failure. These features include circulatory congestion, blunted heart rate responsiveness to adrenergic stimulation, elevated plasma norepinephrine, decreased myocardial norepinephrine, and uniform decreases in flAR number, cAMP production, and cardiac Gs. The biochemical findings occurred in the setting of normal cardiac histology and in the absence of pharmacological interventions, suggesting that circulatory congestion, with attendant elevation in plasma norepinephrine, may be a sufficient stimulus to induce such changes. The data are compatible with a catecholamine-driven ,lAR pathway desensitization. Thus, a primary defect in intrinsic contractile function is not a necessary component for abnormalities of the myocardial l3AR-responsive adenylyl cyclase pathway.
